Statistics in Biopharmaceutical Research
Statistics in Biopharmaceutical Research
期刊ISSN: 1946-6315
E-ISSN: -
影响因子: 登录后查看数据
自引率: 23.1%
SCI期刊JCR分区
SCI期刊JCR分区等级:2区
按学科分区
MATHEMATICAL & COMPUTATIONAL BIOLOGY
Q4
STATISTICS & PROBABILITY
Q2
MATHEMATICAL & COMPUTATIONAL BIOLOGY
Q3
STATISTICS & PROBABILITY
Q2
《新锐期刊分区表》(2026年3月发布)
大类学科
医学
4区
小类学科
数学与计算生物学
4区
统计学与概率论
4区
Top期刊
综述期刊
最新中科院SCI期刊分区(2025年3月升级版)
大类学科
医学
4区
小类学科
数学与计算生物学
3区
统计学与概率论
4区
Top期刊
综述期刊
期刊简介
Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems. Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application). The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review. Authors can choose to publish gold open access in this journal.
出版信息
出版商
Taylor and Francis Ltd.
涉及的研究方向
MATHEMATICAL & COMPUTATIONAL BIOLOGY-STATISTICS & PROBABILITY
刊期
Quarterly
年文章数
52
出版国家或地区
UNITED STATES
是否OA
Cite Score(2025年最新版)
Cite Score SJR SNIP 排名
2.8 0.749 0.944
学科
大类学科:Mathematics
小类学科:Statistics and Probability
分区
Q2
学科
大类学科:Mathematics
小类学科:Pharmaceutical Science
分区
Q3
SCI期刊投稿推荐
JCR分区相关期刊
中科院分区相关期刊
去登录